The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of less frequent dosing with elranatamab (ELRA) in patients with relapsed or refractory multiple myeloma (RRMM): A US subgroup analysis from MagnetisMM-3.
 
Ajay Nooka
Honoraria - Adaptive Biotechnologies; AstraZeneca; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; K36 therapeutics; ONK Therapeutics; Pfizer; Sebia
Consulting or Advisory Role - Adaptive Biotechnologies; AstraZeneca; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; k36 therapeutics; ONK Therapeutics; Pfizer; Sebia
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Christopher Strouse
No Relationships to Disclose
 
Sarah Larson
Stock and Other Ownership Interests - 1200 Pharma; Torl Biotherapeutics
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Abbvie; Allogene Therapeutics (Inst); BiolineRx; Bristol-Myers Squibb; Celgene; Janssen Oncology; Kite, a Gilead company; Lyell Immunopharma; Novartis; Pfizer (Inst); Sanofi (Inst)
 
Alexander Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; SVB Leerink; SVB Leerink; Trillium Therapeutics
Consulting or Advisory Role - Arcellx; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Asya Varshavsky Yanovsky
Consulting or Advisory Role - BMS; Janssen; Pfizer
Patents, Royalties, Other Intellectual Property - US patent 9155781
 
David Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
 
Guenther Koehne
No Relationships to Disclose
 
Elpitha Soussou
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Sharon Sullivan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Noopur Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Immuneel Therapeutics; Janssen Oncology; Merck; Pfizer; Takeda
Research Funding - Bluebird Bio (Inst); Pfizer (Inst)